Patent ID: 9394350
Filing Date: 2016-07-19
CPC Classification: A61K,A61P,C07K

Claim Text:
1. A composition comprising an adjuvant and a peptide comprising a cytotoxic T-cell lymphocyte (CTL) epitope KVFGSLAFV (SEQ ID NO: 7) and a peptide comprising a cytotoxic T-cell lymphocyte (CTL) epitope YLSGADLNL (SEQ ID NO:8), each peptide being less than 15 amino acid residues in length, and the composition further comprising (a) at least three additional peptides, wherein each of said three peptides is less than 15 amino acid residues in length and comprises a cytotoxic T-cell lymphocyte (CTL) epitope selected from the group consisting of KLBPVQLWV (SEQ ID NO:6), SMPPPGTRV (SEQ ID NO:5), IMIGHLVGV (SEQ ID NO:9), LLTFWNPPV (SEQ ID NO:4), KVAEIVHFL (SEQ ID NO:10), RLLQETELV (SEQ ID NO:2), and YLQLVFGIEV (SEQ ID NO:3).